Design of the MERCURION-IPF trial – intravenous immunoglobulin for the treatment of acute exacerbations of idiopathic pulmonary fibrosis

IntroductionDespite their profound clinical impact and high mortality, acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) still lack any effective or standardized treatment strategies. This manuscript describes the rationale and design of a randomized, multicenter, open-label Phase III cl...

Cijeli opis

Bibliografski detalji

Glavni autori:	Vasilina Sotiropoulou, Fotios Sampsonas, Eirini Vasarmidi, Katerina Antoniou, Athena Gogali, Konstantinos Kostikas, Fotios Drakopanagiotakis, Paschalis Steiropoulos, George Margaritopoulos, Konstantinos Porpodis, Zoe Daniil, Ioannis Tomos, Ilias Papanikolaou, Vasilios Tzilas, Stelios Loukides, Argyrios Tzouvelekis
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-05-01
Serija:	Frontiers in Immunology
Teme:	acute exacerbation of idiopathic pulmonary fibrosis clinical trial idiopathic pulmonary fibrosis intravenous immunoglobulin protocol
Online pristup:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1777564/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!